*Ingnstrng - my guess on the development of FAIMS, is about the same amount of time that the Breathtec device will take for it's development proposed in their prospectus recently. About 1 year for development and trial initiation.
I don't think Hound Labs will be any quicker.
I think the most important thing for all investors to realize is that, Cannabix has been quiet, they don't need to announce every small advance. Yost has probably suggested they don't. The new UFL agreement puts a damper on the ability to release tons of news, and who wants to give away all the secrets. At the end of the day, investors should care about the following ... is management making advances to develop the FAIMS device, because, the FAIMS device is the technology with the most potential in the world in terms of accuracy. We also have the most talented advisor for the job in Yost. Simple. Cannabix, HAS IMHO made timely advances and when Alpha didn't work, they pulled through for shareholders in announcing the UFL partnership. I don't see any issue so far. While some will say management has let shareholders down, I would disagree. They worked on Breathtec, so what, if they have Yost working on the Cannabix device and *hired Boock*, then they have time to work on Breathtec because they are businessmen, and Yost and Boock are working hard on a device, and that work just began, so of course there won't be an announcememt ready. Even if all the investors on this forum teamed up, they wouldn't be able to develop a Yost quality device. Even if all the investors on this form worked together for 40 years, it wouldn't happen. Yost is a special, genius, world renowned chemist.
News 
Market Data 
Discover 
AI
